Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMTX Immatics N.V.

盘后交易 05-07 18:04:38 EDT

4.39

-0.20

-4.36%

盘后4.39

+0.000.00%

16:05 EDT

最高4.71	最低3.94	成交量79.69万
今开4.61	昨收4.59	日振幅16.78%
总市值5.34亿	流通市值2.69亿	总股本1.22亿
成交额339.75万	换手率1.30%	流通股本6,133万
市净率0.82	ROE3.84%	每股收益0.14
52周最高13.77	52周最低3.30	市盈率30.29
股息0.00	股息收益率0.00	ROA-4.00%

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMTX","market":"US","secType":"STK","nameCN":"Immatics N.V.","latestPrice":4.39,"timestamp":1746648000000,"preClose":4.59,"halted":0,"volume":796878,"hourTrading":{"tag":"盘后","latestPrice":4.39,"preClose":4.39,"latestTime":"16:05 EDT","volume":97,"amount":425.83,"timestamp":1746648313037},"delay":0,"floatShares":61327177,"shares":121550169,"eps":0.144943,"marketStatus":"盘后交易","change":-0.2,"latestTime":"05-07 18:04:35 EDT","open":4.61,"high":4.71,"low":3.94,"amount":3397545.13446,"amplitude":0.167756,"askPrice":5.9,"askSize":200,"bidPrice":4,"bidSize":400,"shortable":0,"etf":0,"ttmEps":0.144943,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746662400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":4.59,"postHourTrading":{"tag":"盘后","latestPrice":4.39,"preClose":4.39,"latestTime":"16:05 EDT","volume":97,"amount":425.83,"timestamp":1746648313037},"volumeRatio":1.675402,"impliedVol":0.5431,"impliedVolPercentile":0.604},"requestUrl":"/m/hq/s/IMTX","defaultTab":"news","newsList":[{"id":"2533693686","title":"Immatics N.V.盘中异动 早盘快速下挫5.45%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533693686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533693686?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:44","pubTimestamp":1746625446,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时44分，Immatics N.V.股票出现波动，股价大幅下挫5.45%。截至发稿，该股报4.34美元/股，成交量2.3407万股，换手率0.02%，振幅7.84%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.31%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721440694ef53e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721440694ef53e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2533650529","title":"Immatics N.V.盘中异动 快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650529?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:46","pubTimestamp":1746549987,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时46分，Immatics N.V.股票出现异动，股价快速下跌5.10%。截至发稿，该股报4.84美元/股，成交量22.3508万股，换手率0.18%，振幅7.45%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为5.55%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070046279750e4e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070046279750e4e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2532847328","title":"Immatics N.V.盘中异动 早盘股价大涨5.39%报5.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532847328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532847328?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:54","pubTimestamp":1746194042,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时54分，Immatics N.V.股票出现异动，股价快速拉升5.39%。截至发稿，该股报5.28美元/股，成交量1.4736万股，换手率0.01%，振幅4.39%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.31%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502215403974d684c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502215403974d684c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2530281201","title":"Immatics N.V.盘中异动 早盘急速拉升5.31%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530281201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530281201?lang=zh_cn&edition=full","pubTime":"2025-04-28 22:00","pubTimestamp":1745848811,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时00分，Immatics N.V.股票出现波动，股价快速上涨5.31%。截至发稿，该股报4.76美元/股，成交量1.5178万股，换手率0.01%，振幅4.54%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.91%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428220012a46a9613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428220012a46a9613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2529807681","title":"Immatics N.V.盘中异动 早盘股价大涨5.32%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529807681?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415046,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分，Immatics N.V.股票出现异动，股价快速拉升5.32%。截至发稿，该股报4.55美元/股，成交量2019股，换手率0.00%，振幅0.00%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213047a6c53c15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213047a6c53c15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2517496129","title":"Immatics N.V.盘中异动 快速上涨5.07%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517496129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517496129?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:35","pubTimestamp":1741188909,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时35分，Immatics N.V.股票出现异动，股价急速拉升5.07%。截至发稿，该股报4.56美元/股，成交量15.1305万股，换手率0.12%，振幅4.15%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.21%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233510963aeccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233510963aeccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2514049232","title":"Immatics N.V.盘中异动 临近收盘股价大跌5.27%报4.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514049232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514049232?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:54","pubTimestamp":1740516876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时54分，Immatics N.V.股票出现异动，股价急速下跌5.27%。截至发稿，该股报4.41美元/股，成交量31.5867万股，换手率0.26%，振幅5.91%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.06%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045436a253de03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045436a253de03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2510803843","title":"Immatics N.V.盘中异动 早盘股价大跌5.41%报4.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510803843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510803843?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:43","pubTimestamp":1739285034,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时43分，Immatics N.V.股票出现异动，股价大幅跳水5.41%。截至发稿，该股报4.99美元/股，成交量3.7235万股，换手率0.03%，振幅3.61%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为1.36%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224354abcb08fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224354abcb08fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2509775354","title":"Immatics N.V.盘中异动 快速下跌5.04%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509775354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509775354?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:01","pubTimestamp":1738958481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时01分，Immatics N.V.股票出现波动，股价快速跳水5.04%。截至发稿，该股报5.37美元/股，成交量23.8529万股，换手率0.20%，振幅4.78%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.66%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040121961b6f8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040121961b6f8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2509234140","title":"Immatics N.V.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509234140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509234140?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:31","pubTimestamp":1738776697,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时31分，Immatics N.V.股票出现异动，股价急速拉升5.07%。截至发稿，该股报5.70美元/股，成交量15.5771万股，换手率0.13%，振幅6.27%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为2.00%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206013137961926c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206013137961926c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2508272991","title":"Immatics N.V.盘中异动 下午盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508272991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508272991?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:13","pubTimestamp":1738613586,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时13分，Immatics N.V.股票出现异动，股价大幅下跌5.03%。截至发稿，该股报5.20美元/股，成交量24.6576万股，换手率0.20%，振幅3.66%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.29%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020404130698799d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020404130698799d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2504485299","title":"Immatics N.V.盘中异动 股价大跌5.04%报5.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504485299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504485299?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:27","pubTimestamp":1737048434,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时27分，Immatics N.V.股票出现异动，股价快速下跌5.04%。截至发稿，该股报5.46美元/股，成交量26.5531万股，换手率0.22%，振幅5.48%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.21%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117012714abad75de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117012714abad75de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2503640319","title":"Immatics N.V.盘中异动 大幅上涨5.86%报6.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640319?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951553,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Immatics N.V.股票出现波动，股价快速上涨5.86%。截至发稿，该股报6.32美元/股，成交量1.1635万股，换手率0.01%，振幅3.18%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.77%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232349604b426&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232349604b426&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2503708584","title":"Immatics N.V.盘中异动 早盘快速下跌5.44%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503708584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503708584?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:01","pubTimestamp":1736784090,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时01分，Immatics N.V.股票出现异动，股价急速跳水5.44%。截至发稿，该股报6.08美元/股，成交量15.5791万股，换手率0.13%，振幅5.37%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.95%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114000130aba94707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114000130aba94707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2502681356","title":"Immatics N.V.盘中异动 下午盘股价大跌5.02%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502681356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502681356?lang=zh_cn&edition=full","pubTime":"2025-01-11 02:15","pubTimestamp":1736532937,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日02时15分，Immatics N.V.股票出现异动，股价快速下挫5.02%。截至发稿，该股报6.62美元/股，成交量21.8234万股，换手率0.18%，振幅5.60%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为1.94%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111021537aba63414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111021537aba63414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2500412957","title":"Immatics N.V.盘中异动 临近收盘股价大跌5.05%报7.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500412957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500412957?lang=zh_cn&edition=full","pubTime":"2025-01-04 04:34","pubTimestamp":1735936450,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日04时34分，Immatics N.V.股票出现异动，股价快速下跌5.05%。截至发稿，该股报7.05美元/股，成交量42.4681万股，换手率0.35%，振幅5.93%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.63%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104043410a214b039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104043410a214b039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2500292070","title":"Immatics N.V.盘中异动 快速拉升5.06%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500292070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500292070?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:15","pubTimestamp":1735830910,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时15分，Immatics N.V.股票出现波动，股价急速上涨5.06%。截至发稿，该股报7.47美元/股，成交量8.7296万股，换手率0.07%，振幅5.63%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.96%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231510ab9c0175&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231510ab9c0175&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2492153781","title":"Immatics N.V.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492153781?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:05","pubTimestamp":1734552357,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时05分，Immatics N.V.股票出现波动，股价快速下跌5.01%。截至发稿，该股报6.82美元/股，成交量56.4613万股，换手率0.46%，振幅6.27%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为2.02%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040557a1f94cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040557a1f94cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2491500377","title":"Immatics N.V.盘中异动 早盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491500377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491500377?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:26","pubTimestamp":1734107216,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时26分，Immatics N.V.股票出现波动，股价快速下跌5.13%。截至发稿，该股报7.03美元/股，成交量16.4401万股，换手率0.14%，振幅4.32%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.47%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121400265795e97bea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121400265795e97bea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2487059814","title":"Immatics N.V.盘中异动 大幅上涨5.06%报8.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487059814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487059814?lang=zh_cn&edition=full","pubTime":"2024-11-30 01:46","pubTimestamp":1732902417,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日01时46分，Immatics N.V.股票出现波动，股价急速上涨5.06%。截至发稿，该股报8.31美元/股，成交量19.5177万股，换手率0.16%，振幅5.18%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.23%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130014657a25fcf80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130014657a25fcf80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immatics.com","stockEarnings":[{"period":"1week","weight":-0.0575},{"period":"1month","weight":0.3114},{"period":"3month","weight":-0.21},{"period":"6month","weight":-0.5038},{"period":"1year","weight":-0.5726},{"period":"ytd","weight":-0.3544}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.1059},{"period":"3month","weight":-0.0752},{"period":"6month","weight":-0.0618},{"period":"1year","weight":0.0818},{"period":"ytd","weight":-0.0465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immatics N.V.于2020年3月10日成立，是一家荷兰私人有限责任公司。该公司是一家专注于开发基于T细胞受体的免疫疗法的生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.096962},{"month":2,"riseRate":0.6,"avgChangeRate":-0.049146},{"month":3,"riseRate":0.4,"avgChangeRate":-0.055575},{"month":4,"riseRate":0.6,"avgChangeRate":0.030451},{"month":5,"riseRate":0.4,"avgChangeRate":0.052766},{"month":6,"riseRate":1,"avgChangeRate":0.113651},{"month":7,"riseRate":1,"avgChangeRate":0.09814},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003927},{"month":9,"riseRate":0.4,"avgChangeRate":-0.019872},{"month":10,"riseRate":0.4,"avgChangeRate":-0.06624},{"month":11,"riseRate":0.2,"avgChangeRate":-0.045034},{"month":12,"riseRate":0.6,"avgChangeRate":0.023237}],"exchange":"NASDAQ","name":"Immatics N.V.","nameEN":"Immatics N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immatics N.V.,IMTX,Immatics N.V.股票,Immatics N.V.股票老虎,Immatics N.V.股票老虎国际,Immatics N.V.行情,Immatics N.V.股票行情,Immatics N.V.股价,Immatics N.V.股市,Immatics N.V.股票价格,Immatics N.V.股票交易,Immatics N.V.股票购买,Immatics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}